FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series B / Health care startups that raised Series B in Asia

Health care startups that raised Series B in Asia

Updated 16 Nov 2026

Reset
Health care startups that raised Series B in Asia
One-time CSV
  • 1,021 funded companies, 738 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-b~asia.csv1,021 rows × 18 columns
CompanyCityLast roundAmountDate
Huasaiboman Medical Cell BiologyQingdao ShiSeries B$30.0M2026-11-09
EnjosimShanghaiSeries B$30.1M2026-11-02
BionicMTokyoSeries B$4.5M2026-11-02
TroovyGurgaonSeries B$10.5M2026-10-27
Even HealthcareBangaloreSeries B$50.0M2026-10-19
Hyperway PharmChengduSeries B$14.9M2026-10-15
Celaid TherapeuticsTokyoSeries B$2.5M2026-10-05
HITSSeoulSeries B$13.5M2026-09-28

8 rows of the CSV in 5 of its 18 columns.

1,021
Startups
$21.6B
Total raised
151
Funded in the last 12 months
$2.4B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 1,021
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Huasaiboman Medical Cell Biology Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. Biotech Qingdao Shi, China Series B $30.0M 2026-11-09 $30.0M ASBV 11 to 50 2019
Enjosim Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. Biotech Shanghai, China Series B $30.1M 2026-11-02 $30.1M Luminous Ventures (former Lightspeed China Partners), Jiayuan Capital 51 to 100 2021
BionicM BionicM develops high-performance robotic prostheses that improve mobility for people with disabilities. Hardware Tokyo, Japan Series B $4.5M 2026-11-02 $15.5M UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, Shinsei Corporate Investment +1 11 to 50 2018
Troovy Troovy makes nutritious foods using natural, wholesome ingredients. Health care Gurgaon, India Series B $10.5M 2026-10-27 $18.5M Veltis Capital 11 to 50 2021
Even Healthcare Even is a health-tech company and healthcare provider partnering directly with top hospitals in India. Fintech Bangalore, India Series B $50.0M 2026-10-19 $140.9M Khosla Ventures, Founders Fund, 8VC +2 101 to 250 2020
Hyperway Pharm Hyperway Pharm conducts pharmaceutical research, development, and production. Health care Chengdu, China Series B $14.9M 2026-10-15 $56.8M Si Chuan Venture Capital, Chengdu High-tech Ceyuan Capital, Huaige Capital +1 51 to 100 2019
Celaid Therapeutics Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. Biotech Tokyo, Japan Series B $2.5M 2026-10-05 $17.1M UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners 1 to 10 2020
HITS HITS develops artificial intelligence software for drug discovery and pharmaceutical research. Artificial intelligence Seoul, South Korea Series B $13.5M 2026-09-28 $25.1M Korea Investment Partners, Capstone Partners, Company K Partners +2 11 to 50 2020
Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Shanghai, China Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
Medefa Medefa uses synthetic biology to mass-produce novel PHA biomaterials. Biotech Zhuhai, China Series B $14.9M 2026-09-02 $16.3M Motianshi Touzi, Taiping Innovation 11 to 50 2019
Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou, China Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019
MileBot Robotics MileBot Robotics develops robots for medical and healthcare applications. Artificial intelligence Shenzhen, China Series B $14.9M 2026-08-26 $14.9M Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital 101 to 250 2016
Butterfly Learnings Butterfly Learnings provides developmental therapy and inclusive education for children. Health care Thane, India Series B $6.8M 2026-08-19 $12.1M Venture Catalysts, 100Unicorns, IIMA Ventures +1 251 to 500 2021
Leadinno Medical Valley Leadinno Medical Valley produces medical devices that regulate neurological functions. Health care Beijing, China Series B $29.7M 2026-08-17 $90.3M Fortune Venture Capital, Cowin Capital, Taiyu Investment +2 10,001 or more 2016
Hongxin Biology Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. Biotech Shenzhen, China Series B $14.0M 2026-08-13 $14.0M Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group 11 to 50 2021
QuantHealth QuantHealth develops AI-powered clinical trial simulation software for pharmaceutical and biotechnology organizations. Artificial intelligence Tel Aviv, Israel Series B $45.0M 2026-08-04 $62.0M Pitango VC, Nina Capital, Accenture Ventures +2 101 to 250 2020
Layerwave Bio Layerwave Bio develops diagnostic instrument reagents and biomedical research instruments. Biotech Daxing, China Series B $13.8M 2026-07-28 $13.8M IDG Capital, Addor Capital, Hotung Venture Capital 51 to 100 2020
MindRank AI MindRank AI develops artificial intelligence platforms to discover and develop small molecule drugs. Artificial intelligence Shanghai, China Series B $52.0M 2026-07-08 $101.0M Green Pine Capital Partners, Huagai Capital, Sherpa Healthcare Partners +1 11 to 50 2020
Sonosemi Medical Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. Health care Shenzhen, China Series B $27.3M 2026-07-08 $27.3M Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 101 to 250 2020
Emoha Elder Care Emoha Elder Care delivers integrated healthcare and support services for elderly people in India. Health care Haryana, India Series B $8.9M 2026-07-02 $21.1M Rainmatter Capital, Gruhas, Lumis Partners 51 to 100 2019
The Indus Valley The Indus Valley makes cookware designed to help people prepare healthy and delicious meals. Commerce Chennai, India Series B $17.0M 2026-06-30 $21.0M The Chennai Angels, Lead Invest, DSG Consumer Partners +1 11 to 50 2016
Dentlink Dentlink provides digital solutions that help dental clinics and dentists manage their practices. Health care Mapo, South Korea Series B $7.8M 2026-06-23 $11.2M Springcamp, Translink Investment, Big Basin Capital 11 to 50 2021
Plco Plco develops a sports platform that helps teams and coaches manage player data and performance analytics. Health care Seocho, South Korea Series B $2.7M 2026-06-16 $9.9M TIPS Program, Lotte Ventures, Schmidt +1 11 to 50 2018
Immuneel Therapeutics Immuneel Therapeutics develops cell and gene therapies to treat cancer. Health care Bangalore, India Series B $10.5M 2026-06-08 $37.6M Eight Roads Ventures, F-Prime, True North 51 to 100 2018
PROMEDIUS PROMEDIUS is a healthcare company offering an AI-based medical imaging system for osteoporosis. Artificial intelligence Seoul, South Korea Series B $14.0M 2026-06-05 $24.6M TIPS Program, CNTTECH, Korea Credit Guarantee Fund +2 11 to 50 2019
X-MAGTECH X-MAGTECH provides a technology platform for measuring extremely weak magnetic fields. Health care Haidian, China Series B $14.8M 2026-06-04 $43.5M IDG Capital, CAS Star, Everest Venture Capital +1 101 to 250 2018
HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou, China Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
Menovex Menovex develops and markets laser medical devices for treating oral and skin conditions. Health care Shenzhen, China Series B $14.8M 2026-06-02 $14.8M Infinity Equity 2019
Bivision Bivision researches and develops targeted radiopharmaceuticals for therapy. Biotech Shanghai, China Series B $58.8M 2026-05-18 $100.9M Gaorong Capital, Kaitai Capital, Lichen Capital 11 to 50 2021
Hypershell Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. Artificial intelligence Shenzhen, China Series B $50.0M 2026-05-18 $121.2M MiraclePlus, Decent Capital, Vitalbridge Capital 101 to 250 2021

Table 1. Health care startups that raised Series B in Asia: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,021.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi, China Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
2 Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Shanghai, China Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
3 WIRobotics WIRobotics develops wearable robots that reduce physical strain and support safe human movement. Hardware Yongin, South Korea Series B $63.5M 2026-05-15 $76.1M FuturePlay, Hana Ventures, Company K Partners +2 11 to 50 2021
4 Bivision Bivision researches and develops targeted radiopharmaceuticals for therapy. Biotech Shanghai, China Series B $58.8M 2026-05-18 $100.9M Gaorong Capital, Kaitai Capital, Lichen Capital 11 to 50 2021
5 MindRank AI MindRank AI develops artificial intelligence platforms to discover and develop small molecule drugs. Artificial intelligence Shanghai, China Series B $52.0M 2026-07-08 $101.0M Green Pine Capital Partners, Huagai Capital, Sherpa Healthcare Partners +1 11 to 50 2020
6 Even Healthcare Even is a health-tech company and healthcare provider partnering directly with top hospitals in India. Fintech Bangalore, India Series B $50.0M 2026-10-19 $140.9M Khosla Ventures, Founders Fund, 8VC +2 101 to 250 2020
7 Hypershell Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. Artificial intelligence Shenzhen, China Series B $50.0M 2026-05-18 $121.2M MiraclePlus, Decent Capital, Vitalbridge Capital 101 to 250 2021
8 QuantHealth QuantHealth develops AI-powered clinical trial simulation software for pharmaceutical and biotechnology organizations. Artificial intelligence Tel Aviv, Israel Series B $45.0M 2026-08-04 $62.0M Pitango VC, Nina Capital, Accenture Ventures +2 101 to 250 2020
9 CSR Biotech CSR Biotech provides cell imaging and data processing services for biological research. Biotech Haidian, China Series B $45.0M 2026-03-10 $45.0M Qiming Venture Partners 51 to 100 2019
10 Novamab Novamab researches and develops new nanobodies. Biotech Shanghai, China Series B $43.9M 2026-04-24 $97.8M Qiming Venture Partners, Taiyu Investment, Fuho Capital +1 51 to 100 2017

Table 2. Health care startups that raised Series B in Asia: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 TIPS Program Startup incubator Gangneung, South Korea 15 1% 2 Plco, PROMEDIUS
2 Qiming Venture Partners Venture capital firm Shanghai, China 14 1% 3 Novamab, CSR Biotech, Tingsheng Technology
3 IDG Capital Private equity firm Beijing, China 11 1% 3 Layerwave Bio, X-MAGTECH, Yuewei Medical
4 Matrix Partners China Venture capital firm Beijing, China 9 1% 2 Alioth, D3 Bio
5 Legend Capital Venture capital firm Beijing, China 8 1% 1 Alioth
6 Korea Investment Partners Private equity firm Seoul, South Korea 6 1% 2 HITS, LabInCube
7 Puhua Capital Venture capital firm Hangzhou, China 6 1% 1 Yuce Biotechnology
8 CDH Investments Private equity firm Kowloon City, Hong Kong 6 1% 1 HemaCell
9 Shenzhen Capital Group Venture capital firm Nanshan, China 6 1%
10 HB Investment Micro VC fund Seoul, South Korea 6 1%
11 UTEC - The University of Tokyo Edge Capital Partners Venture capital firm Tokyo, Japan 5 0% 2 BionicM, Celaid Therapeutics
12 BioTrack Capital Venture capital firm Shanghai, China 5 0% 2 Yuce Biotechnology, Rigen Biotech
13 Lenovo Capital and Incubator Group (LCIG) Venture capital firm Beijing, China 5 0% 1 MileBot Robotics
14 Taiyu Investment Venture capital firm Beijing, China 5 0% 3 Leadinno Medical Valley, Novamab, Tingsheng Technology
15 Fortune Venture Capital Venture capital firm Shenzhen, China 5 0% 2 Leadinno Medical Valley, RoboCT

Table 3. Health care startups that raised Series B in Asia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 395 39% $9.8B
Software 173 17% $2.7B
Hardware 76 7% $818.2M
Artificial intelligence 73 7% $1.6B
Commerce 42 4% $2.1B
Fintech 23 2% $515.3M
Education 17 2% $141.6M
Energy 5 0% $31.5M
Cybersecurity 3 0% $30.0M

Table 4. Health care startups that raised Series B in Asia by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 1,021 100% $13.9M

Table 5. Health care startups that raised Series B in Asia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
China 664 65%
South Korea 136 13%
Japan 59 6%
India 58 6%
Israel 51 5%
Singapore 18 2%
Taiwan 10 1%
Hong Kong 9 1%
United Arab Emirates 5 0%
Indonesia 4 0%
Thailand 1 0%
Malaysia 1 0%

Table 6. Health care startups that raised Series B in Asia by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Shanghai 106 10%
Beijing 93 9%
Seoul 56 5%
Hangzhou 55 5%
Shenzhen 53 5%
Suzhou 45 4%
Guangzhou 28 3%
Nanjing 26 3%
Haidian 25 2%
Tokyo 21 2%
Bangalore 18 2%
Chengdu 17 2%

Table 7. Health care startups that raised Series B in Asia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 8 5% $98.3M
October 2026 10 7% $251.1M
September 2026 12 8% $352.9M
August 2026 11 7% $138.6M
July 2026 8 5% $216.1M
June 2026 16 11% $173.1M
May 2026 9 6% $255.3M
April 2026 9 6% $97.6M
March 2026 17 11% $227.4M
February 2026 14 9% $136.4M
January 2026 16 11% $176.6M
December 2025 13 9% $230.5M
November 2025 8 5% $52.7M

Table 8. Health care startups that raised Series B in Asia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 130 13% $2.1B
2025 117 11% $1.7B
2024 96 9% $1.2B
2023 104 10% $1.4B
2022 124 12% $3.2B
2021 100 10% $3.2B

Table 9. Health care startups that raised Series B in Asia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 6 1%
2020 to 2022 126 12%
2015 to 2019 485 48%
2010 to 2014 236 23%
Before 2010 161 16%

Table 10. Health care startups that raised Series B in Asia by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 108 12%
11 to 50 349 37%
51 to 100 187 20%
101 to 250 151 16%
251 to 500 74 8%
501 to 1,000 29 3%
1,001 to 5,000 25 3%
5,001 to 10,000 4 0%
10,001 or more 5 1%

Table 11. Health care startups that raised Series B in Asia by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Asia whose last round is Series B are on the list?
1,021, in the file dated 16 November 2026. 151 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 1,021 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series B in Asia: 1,021 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Asia

Other sectors that raised Series B in Asia

Cite: FundingWatcher, 1,021 health care companies in Asia whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-b/asia/